Publication | Closed Access

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

Emetogenic ChemotherapyOncologyCyclophosphamide RegimensChemotherapy-induced NauseaGastrointestinal OncologyCancer ManagementPharmacologyGastroenterologyPharmacotherapyCancer TreatmentMedicineCancer Research